- Published at
- by gurufocus.com
neutral
neutral
Portage Biotech (PRTG) Resumes Key Clinical Trial Phase
Portage Biotech has resumed patient enrollment in its critical PORT-6 dose escalation trial, showing recovery from past financial setbacks. Analysts pre